Reilly and Noe and Nord are about to reach an agreement with the White House on the price of obesity drugs.

Leila and Nor and Nod plan announced a new drug pricing agreement with the White House, including weight loss drugs, in exchange for insurance coverage for their products. Under the agreement, both companies will offer their respective lowest doses of obesity drugs at a price of $149 per month. The agreement may be announced this week. In return, these drugs will be included in the coverage of the U.S. Federal Medicare program, which is aimed at people aged 65 and older, bringing a range of new huge reimbursement amounts.